about
Evaluation of two-fold fully conditional specification multiple imputation for longitudinal electronic health record data.Two-stage method to remove population- and individual-level outliers from longitudinal data in a primary care database.The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database.Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.Case mix, outcomes and comparison of risk prediction models for admissions to adult, general and specialist critical care units for head injury: a secondary analysis of the ICNARC Case Mix Programme DatabaseDetection of Outliers Due to Participants' Non-Adherence to Protocol in a Longitudinal Study of Cognitive DeclineDrotrecogin alfa (activated): real-life use and outcomes for the UKOutcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infectionsAdmission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.Outcomes following oesophagectomy in patients with oesophageal cancer: a secondary analysis of the ICNARC Case Mix Programme Database.PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.Does the presence of a urinary catheter predict severe sepsis in a bacteraemic cohort?Post hoc insights from PAC-Man--the U.K. pulmonary artery catheter trial.The characteristics and outcome of bacteraemia in renal transplant recipients and non-transplant renal patients.The utility of a blood culture database to identify patients suitable for outpatient parenteral antibiotic treatment.Assessment of an incentivised scheme to provide annual health checks in primary care for adults with intellectual disability: a longitudinal cohort study.Outcomes in consecutive hospitalized UK patients with bacteraemia or fungaemia caused by medical devices and procedures.Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia.The increasing burden of alcoholic liver disease on United Kingdom critical care units: secondary analysis of a high quality clinical database.30-day mortality in UK patients with bacteraemic community-acquired pneumonia.Outcome following admission to UK intensive care units after cardiac arrest: a secondary analysis of the ICNARC Case Mix Programme Database.Does pattern mixture modelling reduce bias due to informative attrition compared to fitting a mixed effects model to the available cases or data imputed using multiple imputation?: a simulation studyHealth indicator recording in UK primary care electronic health records: key implications for handling missing dataA new measure of acute physiological derangement for patients with exacerbations of obstructive airways disease: the COPD and Asthma Physiology ScoreIs Escherichia coli bacteraemia preventable?The effects of critical care outreach services before and after critical care: a matched-cohort analysis
P50
Q30811574-16021739-460B-4FFE-BD39-67BAC27EB895Q34066786-2985FF00-FE78-4996-91AC-6BA20679006EQ34999455-E067A5C5-6A55-4BE1-B39B-D82E6970CFA3Q35578955-6944E259-071E-4B7C-8D9C-AF0A14B5821EQ35578959-20117708-EC08-4F10-BEBD-A3CD6BED7F06Q35687710-CCBFB945-2A68-4D31-8D19-5949FE3D5C96Q36749140-03D9E5F6-6F78-4A89-B67B-39DECE7DC65BQ36876685-09931E26-3A56-43CF-8DC6-3983FB660FBAQ37360381-1FD654E4-8935-4766-BC18-BB58A03FA0AAQ37468518-13B7BDE8-B97D-4DD9-9A4C-2FC936DB9305Q37607330-A4801373-A87B-4223-9802-2EB9B6255EF0Q38959670-007F53B3-4E76-4692-B6EE-C49C47F322DFQ39051846-9A83B06B-4951-4074-A903-0F87C43175F0Q39801170-622DC771-C440-47C2-83F9-46295119E010Q40460867-1F67FD0B-0708-48FD-A0DB-F58A8F214668Q40548941-7DBD3C5A-324A-41D3-85B9-3F9F49C44CA2Q41051211-25A1BC34-4AB5-491C-8B99-B40D9221AE81Q44489498-791B62AC-3A5A-4EE7-A5CF-CCF8D1FFB188Q45067345-C9CD1E47-0039-45AA-A38D-40A4A23C8703Q45894879-183A70E9-0DC3-4665-BA07-6EB1A8FA37DDQ46908556-F978A0EF-F312-495F-A23F-CF235A052FC1Q58696714-CFAEB68B-46EF-48A4-86B1-131DD268258BQ63352672-65975FE5-EC30-467E-ADEE-EF5CFD8C5533Q80579486-B9708452-F7C1-4A18-9C6D-5F8D6453E372Q83333359-256CA2A6-0C6C-4082-8C9B-B75F665ABCBAQ84377099-50E41A68-476F-4FD7-BD10-B0A63C1CC1CE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Catherine Welch
@ast
Catherine Welch
@en
Catherine Welch
@es
Catherine Welch
@nl
type
label
Catherine Welch
@ast
Catherine Welch
@en
Catherine Welch
@es
Catherine Welch
@nl
altLabel
Welch C
@en
prefLabel
Catherine Welch
@ast
Catherine Welch
@en
Catherine Welch
@es
Catherine Welch
@nl
P106
P1153
56217321500
P21
P31
P496
0000-0002-6687-964X